Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-23T08:58:19.267Z Has data issue: false hasContentIssue false
  • English
  • Français

Blood pressure regulation and micronutrients

Published online by Cambridge University Press:  14 December 2007

Krishnamurti Dakshinamurti  and
Shyamala Dakshinamurti
Krishnamurti Dakshinamurti*
Affiliation:
Department of Biochemistry and Medical Genetics, Faculty of Medicine, University of Manitoba, Winnipeg, CanadaR3E 0W3
Shyamala Dakshinamurti
Affiliation:
Department of Pediatrics and Child Health, Faculty of Medicine, University of Manitoba, Winnipeg, CanadaR3E 0W3
*
*Corresponding author: Dr K. Dakshinamurti, fax +1 204 896 3614, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

This review attempts to delineate the underlying mechanisms leading to the development of hypertension as well as the function of vitamins and minerals in the regulation of blood pressure. Physiological processes that regulate cardiac output and systemic vascular resistance impact on the control of blood pressure. Metabolic abnormalities associated with the tetrad of hypertension, dyslipidaemia, glucose intolerance and obesity share insulin resistance, which might be organ or cell specific, as an underlying feature representing different tissue manifestation of a common cellular ionic defect. As Ca is at the centre of ionic regulation of cellular functions, vitamins involved in Ca regulation have a significant role in the control of blood pressure. The endothelium-dependent vasodilator, NO, is susceptible to oxidative damage. Hence, antioxidant vitamins and related factors regulate blood pressure through protection of NO. Robust evidence for the involvement of vitamin B6 (pyridoxine), vitamin C, vitamin D and vitamin E in the regulation of blood pressure have been reported. The well-known roles of Na, K, Ca, Mg and Cl have been explored further. The action of various vitamins on blood pressure regulation cannot always be explained on the basis of their conventionally recognised “vitamin function”. The non-traditional functions of vitamins and their derivatives can be exploited as an adjunct to available pharmacological modalities in the treatment of hypertension.

Keywords

Hypertension mechanismsMicronutrientsVitaminsIon channelsCalcium: Pyridoxal phosphate
Type
Research Article
Information
Nutrition Research Reviews , Volume 14 , Issue 1 , June 2001 , pp. 3 - 44
Copyright
Copyright © CABI Publishing 2001

References

Altura, BM & Altura, BT (1995) Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherosclerosis. Cellular and Molecular Biology Research 41, 347–359.Google Scholar
Altura, BM, Altura, BT, Gebrewold, A, Ising, H & Gunther, T (1984) Magnesium deficiency and hypertension: correlation between magnesium deficient diets and microcirculatory changes in situ. Science 223, 1315–1317.CrossRefGoogle ScholarPubMed
Altura, BM, Altura, BT, Gebrewold, A, Ising, H & Gunther, T (1992) Noise-induced hypertension and magnesium in rats: relationship to microcirculation and calcium. Journal of Applied Physiology 72, 194–202.CrossRefGoogle ScholarPubMed
Anand-Srivastava, MB (1997) Atrial natriuretic peptide-C receptor and membrane signaling in hypertension. Journal of Hypertension 15, 815–826.CrossRefGoogle ScholarPubMed
Anand-Srivastava, MB, de Champlain, J & Thibault, C (1993) DOCA-salt hypertensive rat hearts exhibit altered expression of G-proteins. American Journal of Hypertension 6, 72–75.CrossRefGoogle ScholarPubMed
Anand-Srivastava, MB & Trachte, GJ (1993) Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacological Reviews 45, 455–497.Google ScholarPubMed
Anderson, EA, Hoffman, RP & Balon, TW (1991) Hyperinsulinemia produced both sympathetic neural activation and vasodilation in normal humans. Journal of Clinical Investigation 87, 2246–2252.CrossRefGoogle ScholarPubMed
Appel, LJ, Moore, TJ, Obrzanek, E, Vollmer, WM, Svetskey, LP, Sacks, FM, Bray, GA, Vogt, TM, Cutlet, JA, Windhauser, MM, Lin, P-H & Karanja, N (1997) DASH Collaborative Research Group: a clinical trial of the effects of dietary patterns on blood pressure. New England Journal of Medicine 336, 1117–1124.CrossRefGoogle Scholar
Arvola, P, Ruskoaho, H & Portsi, I (1993) Effects of high calcium diet on arterial smooth muscle functions and electrolyte balance in mineralo-corticoid-salt hypertensive rat. British Journal of Pharmacology 106, 948–958.CrossRefGoogle Scholar
Ascherio, A, Rimm, EB & Giovannuchi, EL (1992) A prospective study of nutritional factors and hypertension among US men. Circulation 86, 1475–1484.CrossRefGoogle ScholarPubMed
Ascherio, A, Rimm, EB, Hernan, MA, Giovannuchi, EL, Kawachi, I, Stampfer, MJ & Willett, WC (1998) Intake of potassium, magnesium, calcium and fibre and risk of stroke among US men. Circulation 98, 1198–1204.CrossRefGoogle ScholarPubMed
Auwerx, J, Bouillon, R & Kesteloot, H (1992) Relation between 25,hydroxyvitamin D3, apolipoprotein cholesterol. Arteriosclerosis and Thrombosis 14, 671–674.CrossRefGoogle Scholar
Ayback, M, Sermet, A, Ayyilidiz, MO & Karakilcik, AZ (1995) Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Drug Research 45, 1271–1273.Google Scholar
Baksi, SN, Abhold, RH & Speth, RC (1989) Low calcium diet increases blood pressure and alters peripheral but not central angiotensin II binding sites in rats. Journal of Hypertension 7, 423–427.CrossRefGoogle Scholar
Balarajan, R, Yuen, P & Machin, D (1987) Inequalities in health: changes in RHA's in the past decade. British Medical Journal 294, 1561–1564.CrossRefGoogle Scholar
Barbagallo, M, Dominguez, LJ, Tagliamonte, MR, Resnick, LM & Paolisso, G (1999) Effects of vitamin E and glutathione on glucose metabolism. Role of magnesium. Hypertension 34, 1002–1006.CrossRefGoogle ScholarPubMed
Barger-Lux, MJ & Heaney, RP (1994) The role of calcium intake in preventing bone fragility, hypertension and certain cancers. Journal of Nutrition 124, 1406S–1411S.CrossRefGoogle ScholarPubMed
Bates, CJ, Prentice, A, Cole, TJ, Van der Pols, JC, Doyle, W, Finch, S, Smithers, G & Clarke, PC (1999) Micronutrients: highlights and research challenges from the 1994–5 National Diet and Nutrition Survey of people aged 65 years and over. British Journal of Nutrition 82, 7–15.CrossRefGoogle ScholarPubMed
Belizan, JM & Villar, J (1980) The relationship between calcium intake and edema, proteinuria and hypertension-gestosis: an hypothesis. American Journal of Clinical Nutrition 33, 2202–2210.CrossRefGoogle Scholar
Belizan, JM, Villar, J, Gonzalez, L, Campodonico, L & Bergal, E (1991) Calcium supplementation to prevent hypertensive disorders of pregnancy. New England Journal of Medicine 325, 1399–1405.CrossRefGoogle ScholarPubMed
Bender, DA (1999) Non-nutritional uses of vitamin B6. British Journal of Nutrition 81, 7–20.CrossRefGoogle ScholarPubMed
Bender, DA & Totoe, L (1984) High doses of vitamin B6 are associated with inhibition of hepatic tryptophan metabolism and increased uptake of tryptophan into the brain. Journal of Neurochemistry 43, 269–275.CrossRefGoogle ScholarPubMed
Berthelot, A & Esposito, J (1983) Effects of dietary magnesium on the development of hypertension in the spontaneously hypertensive rat. Journal of the American College of Nutrition 4, 345–353.Google Scholar
Boarder, MR & Hourani, SMO (1998) The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends in Pharmacological Science 19, 99–107.CrossRefGoogle ScholarPubMed
Boucher, BJ (1998) Inadequate vitamin D status: does it contribute to the disorders comprising syndrome “x”? British Journal of Nutrition 79, 315–327.CrossRefGoogle Scholar
Brickman, AS, Nyby, MD, von Hungen, K, Eggena, P & Tuck, ML (1990) Calcitropic hormones, platelet calcium and blood pressure in essential hypertension. Hypertension 16, 515–522.CrossRefGoogle ScholarPubMed
Brussard, JH, Lowik, MRH, Van den Berg, H, Brants, HAM & Kistemaker, C (1997) Micronutrient status, with special reference to vitamin B6. European Journal of Clinical Nutrition 51, Suppl. 3, S32–S38.Google Scholar
Bukoski, RD, DeWan, P & McCarron, DA (1989) 1,25 (OH)2 vitamin D3 modifies growth and contractile function of vascular smooth muscle of spontaneously hypertensive rats. American Journal of Hypertension 2, 533–556.CrossRefGoogle ScholarPubMed
Bukoski, RD, Ishibashi, K & Bian, K (1995) Vascular actions of the calcium-regulating hormones. Seminars in Nephrology 15, 536–549.Google ScholarPubMed
Bukoski, RD & Kremer, D (1991) Calcium-regulating hormones in hypertension: vascular actions. American Journal of Clinical Nutrition 54, 220S–226S.CrossRefGoogle ScholarPubMed
Bukoski, RD, Wagman, DW & Wang, D (1990) Injection of 1,25 vitamin D enhances resistance artery contractile properties. Hypertension 16, 523–531.CrossRefGoogle ScholarPubMed
Bulpitt, CJ (1990) Vitamin C and blood pressure. Journal of Hypertension 8, 1071–1075.CrossRefGoogle ScholarPubMed
Burgess, ED, Hawkins, RG & Watanabe, M (1990) Interaction of 1,25-dihydroxy vitamin D and plasma renin activity in high renin essential hypertension. American Journal of Hypertension 3, 903–905.CrossRefGoogle Scholar
Burgess, E, Lewanczuk, R, Bolli, P, Chockalingam, A, Cutler, H, Taylot, G & Hamet, P (1999) Recommendations on potassium, magnesium and calcium. Canadian Medical Association Journal 160, Suppl. 9, S35–S45.Google ScholarPubMed
Campese, VM, Romoff, MS & Levitan, D (1982) Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney International 21, 371–378.CrossRefGoogle ScholarPubMed
Canadian Recommendations for the Management of Hypertension (1999) Canadian Medical Association Journal 161, S1–S22.Google Scholar
Catterall, WA, Seage, MJ & Takahashi, M. (1998) Molecular properties of dihydropyridine-sensitive calcium channels in skeletal muscle. Journal of Biological Chemistry 263, 3535–3538.CrossRefGoogle Scholar
Ceriello, A, Giugliano, D, Quatraro, A & Lefebvre, PJ (1991) Antioxidants show an antihypertensive effect in diabetics and hypertensive subjects. Clinical Science 81, 739–742.CrossRefGoogle ScholarPubMed
Chen, CJ, Hsuek, Ym, Lai, MS, Shyu, MP, Chen, SY, Wu, MM, Kuo, TL & Tai, TY (1995) Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25, 53–60.CrossRefGoogle ScholarPubMed
Chen, YF, Meng, Q & Wyss, JM (1988) High NaCl diet reduces hypothalamic norepinephrine turnover in hypertensive rats. Hypertension 11, 55–62.CrossRefGoogle ScholarPubMed
Ciaraldi, TP, Kolterman, OG & Olefsky, JM (1981) Mechanism of the post-receptor defect in insulin action in human obesity. Decrease in glucose transport system activity. Journal of Clinical Investigation 68, 875–880.CrossRefGoogle Scholar
Collier, A, Wilson, R, Bradley, H, Thomas, JA & Small, M (1990) Free radical activity in type II diabetes. Diabetic Medicine 7, 27–30.CrossRefGoogle Scholar
Conti, CR (1999) Vitamin C and coronary vasoactivity. European Heart Journal 20, 1615–1617.CrossRefGoogle Scholar
Corvol, MM, Ulman, A & Garabedian, M (1980) Specific nuclear uptake of 24,25-dihydroxycholecalciferol, a vitamin D3 metabolite biologically active in cartilage. FEBS Letters 116, 273–276.CrossRefGoogle ScholarPubMed
Dahl, LK, Leitl, G & Heine, M (1972) Influence of dietary potassium and sodium/potassium molar ratios on the development of salt hypertension. Journal of Experimental Medicine 136, 318–330.CrossRefGoogle ScholarPubMed
Dakshinamurti, K & Lal, KJ (1992) Vitamins and hypertension. World Review of Nutrition and Dietetics 69, 40–73.CrossRefGoogle ScholarPubMed
Dakshinamurti, K, Lal, KJ, Dhalla, NS, Musat, S & Wang, Xi (2000) Pyridoxal 5-phosphate and calcium channels. In Biochemistry and Molecular Biology of Vitamin B6 and PQQ-dependent proteins pp. 307–314 [Iriarte, A, Kagan, HM and Martinez-Carrion, M editors]. Basel: Birkhauser Verlag.CrossRefGoogle Scholar
Dakshinamurti, K, Lal, KJ & Ganguly, PK (1998) Hypertension, calcium channels and pyridoxine (vitamin B6). Molecular and Cellular Biochemistry 188, 137–148.CrossRefGoogle ScholarPubMed
Dakshinamurti, K, Paulose, CS, Viswanathan, M, Siow, YL, Sharma, SK & Bolster, B (1990 a) Neurobiology of pyridoxine. Annals of the New York Academy of Sciences 585, 129–144.CrossRefGoogle ScholarPubMed
Dakshinamurti, K, Sharma, SK & Bonke, D (1990 b) Influence of B vitamins on binding properties of serotonin receptors in the CNS of rats. Klinische Wochenschrift 68, 142–148.CrossRefGoogle ScholarPubMed
de Bold, MLK, (1999) Estrogen, natriuretic peptides and the renin-angiotensin system. Cardiovascular Research 41, 524–531.CrossRefGoogle Scholar
Dijkhorst-Oei, LT, Stross, ES, Koomans, HA & Rabelink, TJ (1999) Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo. Journal of Cardiovascular Pharmacology 33, 420–424.CrossRefGoogle ScholarPubMed
Dominiczak, AF & Bohr, DF (1990) Cell membrane abnormalities and the regulation of intracellular calcium concentration in hypertension. Clinical Science 79, 415–423.CrossRefGoogle ScholarPubMed
Drueke, TB (1999) Dietary calcium and blood pressure. American Journal of Hypertension 14, 96–98.Google Scholar
Dubyak, GR & El-Moatassium, C (1993) Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. American Journal of Physiology 265, C577–C606.CrossRefGoogle ScholarPubMed
Duffy, SJ, Gokce, N, Holbrook, M, Huang, A, Frei, B, Kearney, JF Jr & Vita, JA (1999) Treatment of hypertension with ascorbic acid. Lancet 354, 2048–2049.CrossRefGoogle ScholarPubMed
Ellis, JM & McCully, KS (1995) Prevention of myocardial infarction by vitamin B6. Research Communications in Chemical Pathology and Pharmacology 89, 208–220.Google ScholarPubMed
Erin, AN, Spirin, MM & Tabidze, LV (1984) Formation of α-tocopherol complex with fatty acids: a hypothetical mechanism of stabilization of biomembranes by vitamin E. Biochimica et Biophysica Acta 774, 96–102.CrossRefGoogle ScholarPubMed
Evans, RJ & Kennedy, C (1994) Characterization of P2-purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses. British Journal of Pharmacology 113, 853–860.CrossRefGoogle ScholarPubMed
Faure, P, Rossini, E, Lafond, JL, Richard, MJ, Favier, A & Halimi, S (1997) Vitamin E improves the free radical defence system potential and insulin sensitivity of rats fed high fructose diets. Journal of Nutrition 127, 103–107.CrossRefGoogle ScholarPubMed
Feldman, EB, Gold, S, Green, J, Moran, J, Xu, G & Shultz, GG (1992) Ascorbic acid supplements and blood pressure. A four week pilot study. Annals of the New York Academy of Sciences 669, 342–344.CrossRefGoogle ScholarPubMed
Ferrannini, E, Buzzigoli, G & Bonadonna, R (1987) Insulin resistance in essential hypertension. New England Journal of Medicine 317, 350–356.CrossRefGoogle ScholarPubMed
Ferrante, J & Triggle, DJ (1990) Drug and disease-induced regulation of voltage-dependent calcium channels. Pharmacological Reviews 42, 29–44.Google ScholarPubMed
Fields, M (1999) Role of trace elements in coronary heart disease. British Journal of Nutrition 81, 85–86.CrossRefGoogle ScholarPubMed
Fields, M, Lewis, CG, Lure, MD, Burns, WA & Antholine, WE (1993) Low dietary iron prevents free radical formation and heart pathology of copper-deficient rats fed fructose. Proceedings of the Society for Experimental Biology and Medicine 202, 225–231.CrossRefGoogle ScholarPubMed
Flora, JS & Hara, K (1993) Sympathoneural and hemodynamic characteristics of young subjects with mild essential hypertension. Journal of Hypertension 11, 647–655.CrossRefGoogle Scholar
Forte, P, Copland, M, Smith, LM, Milne, E, Sutherland, J & Benjamin, N (1997) Basal nitric oxide synthesis in essential hypertension. Lancet 349, 837–842.CrossRefGoogle ScholarPubMed
Freedman, AM, Mark, IT, Stafford, RE, Dickens, BF, Cassidy, MM, Muesing, RA & Weglicki, WB (1992) Erythrocytes from magnesium-deficient hamsters display an enhanced susceptibility to oxidative stress. American Journal of Physiology 262, C1371–C1375CrossRefGoogle ScholarPubMed
Galley, HF, Thornton, J, Howdle, PD, Walker, BE & Webster, NR (1997) Combination oral antioxidant supplementation reduces blood pressure. Clinical Science 9, 361–365.CrossRefGoogle Scholar
Geleijnse, JM, Wittman, JCM, Back, AAA, den Breejen, JH & Grobbe, DE (1994) Reduction in blood pressure with a low sodium, high magnesium salt in older subjects with mild to moderate hypertension. British Medical Journal 309, 436–440.CrossRefGoogle ScholarPubMed
Gemba, T, Ninomiya, M, Matsunaga, K & Veda, M (1992) Changes in extracellular concentration of amino acids in the hippocampus during cerebral ischemia in stroke-prone SHR, stroke-resistant SHR and normotensive rats. Neuroscience Letters 135, 184–188.CrossRefGoogle ScholarPubMed
Gey, KF, Stahelin, HB & Eicholzer, M (1993) Poor plasma status of carotene and vitamin C is associated with a higher mortality from ischemic heart disease and stroke. Basal prospective study. Clinical Investigation 71, 3–6.Google Scholar
Ghosh, SK, Ekpo, EB, Shah, IU, Gerling, AJ, Jankins, C & Sinclair, AJ (1994) A double blind, placebo-controlled parallel trial of vitamin C treatment in elderly patients with hypertension. Gerontology 40, 268–272.CrossRefGoogle ScholarPubMed
Glossman, H & Striessnig, J (1988) Calcium channels. Vitamins and Hormones 44, 155–328.CrossRefGoogle Scholar
Gonic, HC, Ding, V, Bondy, SC & Vaziri, ND (1997) Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species. Hypertension 30, 1487–1492.CrossRefGoogle Scholar
Goody, HF, Purkins, L, Heatley, RV & Kelleher, J (1991) The effect of vitamin E deficiency on plasma zinc and copper concentrations. Clinical Nutrition 10, 233–235.CrossRefGoogle Scholar
Grassi, G, Catteneo, BM, Seravalle, G, Lanfranchie, A & Mancia, G (1997) Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 31, 68–72.CrossRefGoogle Scholar
Gratacos, E, Casals, E, Deulofen, R, Carrach, V, Alonso, PL & Fortuny, A (1998) Lipid peroxide and vitamin E patterns in pregnant women with different types of hypertension in pregnancy. American Journal of Obstetrics and Gynecology 178, 1072–1076.CrossRefGoogle ScholarPubMed
Griffith, LE, Guyatt, GH, Cook, RJ, Bucher, HC & Cook, DJ (1999) The influence of dietary and non dietary calcium supplementation on blood pressure. American Journal of Hypertension 14, 84–92.CrossRefGoogle Scholar
Grimm, RH, Neaton, JD & Elmer, PJ (1990) The influence of oral potassium chloride on blood pressure in hypertensive men on a low sodium diet. New England Journal of Medicine 322, 569–574.CrossRefGoogle ScholarPubMed
Groop, L, Ekstrand, A & Forsblom, C (1993) Insulin resistance, hypertension and microalbuminuria in patients with type 2 diabetes mellitus. Diabetologia 36, 642–647.CrossRefGoogle Scholar
Groop, L, Forsblom, C & Lehtovirta, M (1996) Metabolic consequences of a family history of NIDDM (the Botnia Study): evidence of sex-specific parental effects. Diabetes 45, 1585–1593.CrossRefGoogle ScholarPubMed
Groop, L, Forsblom, C & Lehtovirta, M (1997) Characterization of the prediabetic state. American Journal of Hypertension 10, 172S–180S.CrossRefGoogle ScholarPubMed
Groz, G, Hantt, G & Kolassa, N (1987) Urapidil and some analogs with hypotensive properties show high affinities for 5-HT binding sites of the 5 HT1A subtype and for α1-adrenoreceptor binding sites. Naunyn-Schmiedeberg's Archives of Pharmacology 336, 597–601.Google Scholar
Haffner, SM, Ferrannini, E, Hazuda, HP & Stern, MP (1992 a) Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension 20, 38–45.CrossRefGoogle ScholarPubMed
Haffner, SM, Miettinen, H, Gaskill, SP & Stern, MP (1992 b) Metabolic precursors of hypertension. Archives of Internal Medicine 156, 1994–2001.CrossRefGoogle Scholar
Haffner, SM, Valdez, RA, Hazuda, HP, Mitchel, BD, Morales, PA & Stern, MP (1996) Prospective analyses of the insulin resistance syndrome (syndrome X). Diabetes 41, 715–722.CrossRefGoogle Scholar
Hatton, IC & McCarron, DA (1994) Dietary calcium and blood pressure in experimental models of hypertension. Hypertension 23, 513–530.CrossRefGoogle ScholarPubMed
Holtback, U, Kruse, MS, Brismar, H & Aperia, A (2000) Intrarenal dopamine co-ordinates the effects of antinatriuretic and natriuretic factors. Acta Physiologica Scandinavica 168, 215–218.CrossRefGoogle Scholar
Hourani, SMO, Loizon, GD & Cusak, NJ (1986) Pharmacological effects of L-AMP-PCP on ATP receptors in smooth muscle. European Journal of Pharmacology 131, 99–103.CrossRefGoogle ScholarPubMed
Huang, BS & Leenen, FHH (1996) Sympathoexcitatory and pressor responses to increased brain sodium and oubain are mediated via brain ANG II. American Journal of Physiology 270, H275–H280Google ScholarPubMed
Istfan, NW, Plaisted, CS & Bistrain, BR (1992) Insulin resistance versus insulin secretion in the hypertension of obesity. Hypertension 19, 385–392.CrossRefGoogle ScholarPubMed
Jacques, PF (1992) Relationship of vitamin C status to cholesterol and blood pressure. Annals of the New York Academy of Sciences 669, 205–214.CrossRefGoogle ScholarPubMed
Janero, DR & Burghardt, B (1988) Myocardial vitamin E (α-tocopherol) contents of SHR & WKY normal rats. International Journal of Vitamin and Nutrition Research 58, 292–294.Google Scholar
Jeserich, M, Schindler, T, Olscherwski, M, Unmussig, M, Just, H & Solzback, U (1999) Vitamin C improves endothelial function of epicardial coronary arteries in patients with hypercholesterolemia or essential hypertension - assessed by cold pressor testing. European Heart Journal 20, 1676–1680.CrossRefGoogle ScholarPubMed
Jespersen, B, Randlov, A, Abrahamsen, J, Fogh-Anderson, J, Olsen, NV & Kanstrup, I-L (1998) Acute cardiovascular effects of 1,25-dihydroxycholecalciferol in essential hypertension. American Journal of Hypertension 11, 659–666.CrossRefGoogle ScholarPubMed
John, S & Schmieder, RE (2000) Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences. Journal of Hypertension 18, 363–374.CrossRefGoogle ScholarPubMed
Julius, S (1996) The evidence for a pathophysiologic significance of the sympathetic overactivity in hypertension. Clinical and Experimental Hypertension 18, 305–321.CrossRefGoogle ScholarPubMed
Julius, S, Gundbrandsson, T, Jamerson, K & Andersson, O (1992) The interconnection between sympathetics, microcirculation and insulin resistance in hypertension. Blood Pressure 1, 9–19.CrossRefGoogle ScholarPubMed
Kanai, H, Matsuzawa, Y & Togunaga, K (1990) Hypertension in obese children: fasting serum insulin levels are closely correlated with blood pressure. International Journal of Obstetrics 14, 1047–1056.Google ScholarPubMed
Kawano, Y, Matsuoka, H, Takshita, S & Omae, T (1998) Effect of magnesium supplementation in hypertensive patients. Assessment by office, home and ambulatory blood pressure. Hypertension 32, 260–265.CrossRefGoogle Scholar
Kawashima, H (1987) Receptor for 1,25 dihydroxy-vitamin D in a vascular cell line derived from rat aorta. Biochemical Biophysical Research Communications 146, 1–6.CrossRefGoogle Scholar
Kesteloot, H & d Geboers, J (1982) Calcium and blood pressure. Lancet 1, 813–815.CrossRefGoogle ScholarPubMed
Khalil-Manesh, F, Gonic, HC, Weiler, FW, Prin, B, Weber, MA, Purdy, R & Reno, Q (1994) Effect of chelation treatment with dimercapto succinic acid on lead-related blood pressure changes. Environmental Research 65, 86–99.CrossRefGoogle Scholar
Khaw, KT & Barrett-Connor, E (1987) Dietary potassium and stroke-associated mortality: a 12-year prospective population study. New England Journal of Medicine 316, 235–240.CrossRefGoogle ScholarPubMed
Kokubun, S & Reuter, H (1984) Dihydropyridine derivatives prolong the open state of calcium channels in cultured cardiac cells. Proceedings of the National Academy of Sciences USA 81, 4824–4827.CrossRefGoogle ScholarPubMed
Krause, S, Buhring, M, Hopfen Muller, W, Holick, MG & Sharma, AM (1998) Ultraviolet B and blood pressure. Lancet 352, 709–710.CrossRefGoogle ScholarPubMed
Krishna, GG (1990) Effect of potassium intake on blood pressure. Journal of the American Society of Nephrology 39, 771–776.Google Scholar
Krishna, GG (1994) Role of potassium in the pathogenesis and treatment of hypertension. American Journal of Medical Sciences 307, S21–S25.Google Scholar
Kugiyama, K, Motoyama, T & Hiroshima, O (1998) Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteris in patients with coronary spastic angina. Journal of the American College of Cardiology 32, 103–109.CrossRefGoogle ScholarPubMed
Lal, KJ & Dakshinamurti, K (1993 a) Hypotensive action of 5-HT receptor agonists in the vitamin B6 deficient hypotensive rat. European Journal of Pharmacology 234, 183–189.Google Scholar
Lal, KJ & Dakshinamurti, K (1993 b) Calcium channels in vitamin B6 deficiency-induced hypertension. Hypertension 11, 1357–1362.CrossRefGoogle ScholarPubMed
Lal, KJ & Dakshinamurti, K (1995) Relationship between low calcium induced hypertension and vitamin B6 status. Journal of Hypertension 13, 327–332.CrossRefGoogle Scholar
Lal, KJ, Dakshinamurti, K & Thliveris, J (1996) The effect of vitamin B6 on the systolic blood pressure of rats in various animal models of hypertension. Journal of Hypertension 14, 355–363.CrossRefGoogle ScholarPubMed
Lal, KJ, Sharma, SK & Dakshinamurti, K (1993) Regulation of calcium influx into vascular smooth muscle by vitamin B6. Clinical and Experimental Hypertension 15, 489–500.CrossRefGoogle ScholarPubMed
Laurant, P, Dalle, M, Berthelot, A & Rayssiguier, Y (1999) Time-course of the change in blood pressure level in magnesium-deficient Wistar rats. British Journal of Nutrition 82, 243–251.CrossRefGoogle ScholarPubMed
Lee, CN, Reed, DM, MacLean, CJ, Yano, K & Chin, D (1988) Dietary potassium and stroke. New England Journal of Medicine 318, 995–996.Google ScholarPubMed
Levine, GN, Frei, B, Koulouris, SN, Gerhard, MD, Kearney, JF & Vita, JA (1996) Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 93, 1107–1113.CrossRefGoogle ScholarPubMed
Lin, H & Young, DB (1994) Interaction between plasma potassium and epinephrine in coronary thrombosis in dogs. Circulation 89, 331–338.CrossRefGoogle ScholarPubMed
Linas, SL (1991) The role of potassium in the pathogenesis and treatment of hypertension. Kidney International 39, 771–789.CrossRefGoogle ScholarPubMed
Lind, L, Wengle, B, Wide, L & Ljunghall, S (1989) Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status: a double-blind, placebo- controlled study. American Journal of Hypertension 2, 20–25.CrossRefGoogle ScholarPubMed
Litwack, G (1988) The glucocorticoid receptor at the protein level. Cancer Research 48, 2636–2640.Google ScholarPubMed
Lovat, LB, Lu, Y, Palmer, AJ, Edwards, R, Fletcher, AE & Bulpit, CJ (1993) Double blind trial of vitamin C in elderly hypertensives. Journal of Human Hypertension 7, 403–405.Google ScholarPubMed
Lucas, MJ, Leveno, KJ & Cunningham, FG (1995) A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. New England Journal of Medicine 333, 201–205.CrossRefGoogle ScholarPubMed
Lyons, D, Webster, J & Benjamin, N (1994) The effect of antihypertensive therapy on responsiveness to local intra-arterial NG-monomethyl-L-arginine in patients with essential hypertension. Journal of Hypertension 14, 1047–1052.Google Scholar
McCabe, RD, Backarich, MA, Srivastava, K & Young, DB (1994) Potassium inhibits free radical formation. Hypertension 24, 77–82.CrossRefGoogle ScholarPubMed
McCabe, RD & Young, DB (1994) Potassium inhibits cultured vascular smooth muscle proliferation. American Journal of Hypertension 7, 346–350.CrossRefGoogle Scholar
McCarron, DA (1985) Is calcium more important than sodium in the pathogenesis of essential hypertension? Hypertension 7, 607–627.CrossRefGoogle ScholarPubMed
McCarron, DA (1998) Diet and blood pressure - the paradigm shift. Science 281, 933–934.CrossRefGoogle ScholarPubMed
McCarron, DA, Morris, CD, Henry, HJ & Stanton, JL (1984) Blood pressure and nutrient intake in the United States. Science 224, 1392–1398.CrossRefGoogle ScholarPubMed
McCarron, DA, Oparil, S, Chait, Ä, Haynes, RB, Kris-Etherton, P, Stern, JS, Resnick, LM, Clark, S, Morris, CD, Hatton, DC, Metz, JA, McMohan, M, Holcomb, S, Snyder, GW & Pi-Sunyer, FX (1997) Nutritional management of cardiovascular risk factors. A randomized clinical trial. Archives of Internal Medicine 153, 154–183.Google Scholar
McCarron, DA, Oparil, S, Resnick, LM, Chait, A, Haynes, B, Kris-Etherton, P, Pi-Sunyer, FX, Stern, JS, Morris, CD, Clark, S, Hatton, DC, Metz, JA, McMohan, M, Holcomb, S & Snyder, GW (1998) Comprehensive nutrition plan improved cardiovascular risk factors in essential hypertension. American Journal of Hypertension 11, 31–40.CrossRefGoogle ScholarPubMed
McCarron, DA & Reusser, ME (1999) Finding consensus in the dietary calcium-blood pressure debate. Journal of the American College of Nutrition 18, 398S–405S.CrossRefGoogle ScholarPubMed
Machlin, IJ & Bendich, A (1987) Free radical tissue damage: protective role of antioxidant nutrients. FASEB Journal 1, 441–445.CrossRefGoogle ScholarPubMed
MacMahon, SW, MacDonald, GJ & Blacket, RB (1985) Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study. Arteriosclerosis 67, 49–55.Google Scholar
Maier, LS, Brandes, R, Pieske, B & Bers, DM (1998) Effects of left ventricular hypertrophy on force and Ca2+ handling in isolated rat myocardium. American Journal of Physiology 274, H1361–H1370Google ScholarPubMed
Malluche, HH, Henry, H, Meyer-Saballek, W, Sherman, S, Massry, SG & Norman, AN (1980) Effects and interactions of 24,25 (OH)2 D3 and 1,25 (OH)2 D3 on bone. American Journal of Physiology 238, E494–E496Google Scholar
Manicardi, V, Camellini, L & Bellodi, G (1986) Evidence for an association of high blood pressure and hyperinsulinemia in obese man. Journal of Clinical Endocrinology and Metabolism 62, 1302–1304.CrossRefGoogle ScholarPubMed
Mancia, G (1997) The sympathetic nervous system in hypertension. Journal of Hypertension 15, 1553–1565.CrossRefGoogle ScholarPubMed
Massry, SG, Iseki, K & Campese, VM (1986) Serum calcium, parathyroid hormone and blood pressure. American Journal of Nephrology 6, 1–28.CrossRefGoogle ScholarPubMed
Merke, J & Norman, AW (1981) Evidence of 24 (R) 25(OH)2 D3 receptor on the parathyroid gland of rachitic chicken. Biochemical and Biophysical Research Communications 100, 551–558.CrossRefGoogle Scholar
Metz, JA, Morris, CD, Roberts, LA, McClung, MR & McCarron, DA (1999) Blood pressure and calcium intake are related to bone density in adult males. British Journal of Nutrition 81, 383–388.CrossRefGoogle ScholarPubMed
Minghetti, PP & Norman, AW (1988) 1,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuitry. FASEB Journal 2, 3043–3053.CrossRefGoogle ScholarPubMed
Mizushima, S, Cappuccio, FP, Nichols, R & Elliot, P (1998) Dietary magnesium intake and blood pressure: a qualitative overview of observational studies. Journal of Human Hypertension 14, 447–453.CrossRefGoogle Scholar
Morales, PA, Mitchell, BD, Valdez, RA, Hazuda, HP, Stern, MP & Haffner, SM (1993) Incidence of non-insulin dependent diabetes mellitus and impaired glucose tolerance in hypertensive subjects: the San Antonio Heart Study. Diabetes 42, 154–163.CrossRefGoogle ScholarPubMed
Moran, JP, Cohen, L, Green, JM, Xu, G, Feldman, EB & Hames, CG (1993) Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. American Journal of Clinical Nutrition 57, 213–217.CrossRefGoogle ScholarPubMed
Moser, M (1999) National recommendations for the pharmacological treatment of hypertension. Archives of Internal Medicine 159, 1403–1406.CrossRefGoogle ScholarPubMed
MRC/BHF (1999) Heart protection study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. European Heart Journal 20, 725–741.CrossRefGoogle Scholar
Murray, ED Jr, Wechter, WJ, Kantochi, D, Wang, W-H, Pham, T, Quiggle, DD, Gibson, KM, Leipold, D & Anner, BM (1997) Endogenous natriuretic factors 7: Biospecificity of a natriuretic δ-tocopherol metabolite LLU-α. Journal of Pharmacology and Experimental Therapeutics 282, 657–662.Google Scholar
Mykkanen, L, Kuusisto, J, Pyorala, K, Laasko, M & Haffner, SM (1994) Increased risk of non-insulin dependent diabetes mellitus in elderly hypertensive subjects. Journal of Hypertension 14, 1425–1432.Google Scholar
Nasir, F, Mazure, A, Gionnoni, F, Gueux, E, Davidson, O & Rayssiguer, Y (1995) Magnesium deficiency modulates hepatic lipogenesis and apolipoprotein gene expression in the rat. Biochimica et Biophysica Acta 1257, 125–132.CrossRefGoogle Scholar
Nelson, D & Taylor, WE (1986) A selective serotonin1A receptor agonist. European Journal of Pharmacology 124, 207–208.CrossRefGoogle Scholar
Ness, AR, Khaw, KT, Bingham, S & Day, NE (1996) Vitamin C status and blood pressure. Journal of Hypertension 14, 503–508.CrossRefGoogle ScholarPubMed
Newaz, MA & Nawal, NNA (1998) Effect of α-tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats. American Journal of Hypertension 11, 1480–1485.CrossRefGoogle ScholarPubMed
Newaz, MA, Nawal, NNA, Rohaizan, CH, Muslim, N & Gapor, A (1999) α-Tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats. American Journal of Hypertension 14, 839–844.CrossRefGoogle Scholar
Ng, LL, Ngkeekwong, FC, Quinn, PA & Davies, JE (1998) Uptake mechanisms for ascorbate and dehydroascorbate in lymphoblasts from diabetic nephropathy and hypertensive patients. Diabetologia 41, 435–442.CrossRefGoogle ScholarPubMed
Ngheim, CX & Rapp, JP (1983) Responses to calcium of chemically skinned vascular smooth muscle from spontaneously hypertensive rats. Clinical and Experimental Hypertension 4, 849–856.Google Scholar
Nosadini, R, Solini, A, Velussi, M, Muollo, B, Frigato, F, Sambataro, M, Cipollina, MR, DeRiva, F, Brocco, I & Crepaldi, G (1994) Impaired insulin-induced glucose uptake by extra hepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes 43, 491–499.CrossRefGoogle ScholarPubMed
Nowack, R, Wiecer, A, Exner, B, Gretz, N & Ritz, E (1993) Chronic lead exposure in rats: effects on blood pressure. European Journal of Clinical Investigation 23, 433–448.CrossRefGoogle ScholarPubMed
Nurminen, M-L, Korpela, R & Vapaatalo, H (1998) Dietary factors in the pathogenesis and treatment of hypertension. Annals of Medicine 30, 143–150.CrossRefGoogle ScholarPubMed
O'Hare, JA, Minaker, KL & Meneilly, GS (1989) Effect of insulin on plasma norepinephrine and 3,4 dihydroxy-phenylalanine in obese men. Metabolism 38, 322–329.CrossRefGoogle Scholar
Overback, A, Zenzen, JG, Ressel, C, Muller, HM & Stumpe, KO (1987) Influence of magnesium on blood pressure and the effect of nifedipine in rats. Hypertension 9, 139–143.CrossRefGoogle Scholar
Palozza, P & Krinsky, NI (1992) Beta carotene and alpha tocopherol are synergistic antioxidants. Archives of Biochemistry and Biophysics 297, 184–187.CrossRefGoogle ScholarPubMed
Pang, PKT & Lewanczuk, RZ (1989) Parathyroid origin of a new circulating hypertensive factor in spontaneously hypertensive rats. American Journal of Hypertension 2, 898–902.CrossRefGoogle ScholarPubMed
Pang, PKT, Narvey, S & Doris, PA (1987) Plasma parathyroid hormone during the development of spontaneous hypertension in rats. Canadian Journal of Physiology and Pharmacology 65, 2386–2389.CrossRefGoogle ScholarPubMed
Paolisso, G & Barbagallo, M (1997) Hypertension, diabetes mellitus and insulin resistance. The role of intracellular magnesium. American Journal of Hypertension 10, 346–355.CrossRefGoogle ScholarPubMed
Paolisso, G, DiMaro, G & Cozzolino, B (1992 a) Chronic magnesium administration enhances oxidative glucose metabolism in thiazid treated hyperensive patients. American Journal of Hypertension 5, 681–686.CrossRefGoogle Scholar
Paolisso, G, DiMaro, G, Pizza, G, D'Amore, A, Scambato, S, Tesauro, P, Varricchio, M & d'Onofrio, F (1992 b) Plasma GHS/GSSG affects glucose homeostasis in healthy subjects and non-insulin dependent diabetics. American Journal of Physiology 263, E435–E440Google Scholar
Paulose, CS & Dakshinamurti, K (1987) Chronic catheterization using vascular access port in rats: blood sampling with minimal stress for plasma catecholamine determination. Journal of Neuroscience Methods 22, 141–146.CrossRefGoogle ScholarPubMed
Paulose, CS, Dakshinamurti, K, Packer, S & Stephens, NL (1986) Hypertension in pyridoxine deficiency. Journal of Hypertension 4, Suppl. 5, S174–S175.Google Scholar
Paulose, CS, Dakshinamurti, K, Packer, S & Stephens, NL (1988) Sympathetic stimulation and hypertension in the pyridoxine-deficient adult rat. Hypertension 11, 387–391.CrossRefGoogle ScholarPubMed
Postnor, YP & Orlov, SN (1985) Ion transport across phasma in primary hypertension. Physiological Reviews 65, 904–905.CrossRefGoogle Scholar
Rahman, M, Tondel, M, Ahmed, SA, Chowdhury, IA, Faruquee, MH & Axelson, O (1999) Hypertension and arsenic exposure in Bangladesh. Hypertension 33, 74–78.CrossRefGoogle ScholarPubMed
Rahn, KH, Barenbrock, M & Hausberg, M (1999) The sympathetic nervous system in the pathogenesis of hypertension. Journal of Hypertension 17, Suppl. 3, S11–S14.Google ScholarPubMed
Rappaport, A, Sturtz, F & Guicheney, P (1985) Regulation of central α-adrenoreceptor by serotonergic denervation. Brain Research 344, 158–161.CrossRefGoogle Scholar
Rapp, JP, Nghiem, CX & Oniwochi, MO (1986) Aortic calcium uptake and efflux in spontaneously hypertensive and inbred Dahl rats. Journal of Hypertension 4, 493–499.CrossRefGoogle ScholarPubMed
Rayssiguier, Y, Durlach, J, Gueux, E, Rock, E & Mazur, A (1993 a) Magnesium and aging: experimental data—importance of oxidative damage. Magnesium Research 3, 369–378.Google Scholar
Rayssiguier, Y, Gueux, E, Bussiere, L, Durlach, J & Mazur, A (1993 b) Dietary magnesium affects susceptibility of lipoproteins and tissue to peroxidation in rats. Journal of the American College of Nutrition 14, 133–137.CrossRefGoogle Scholar
Reaven, GR & Hoffman, BB (1988) Abnormalities of carbohydrate metabolism may play a role in the etiology and clinical course of hypertension. Trends in Pharmacological Science 9, 78–79.CrossRefGoogle ScholarPubMed
Repke, JT, Villar, J, Anderson, C, Pareja, G, Dubin, N & Belizan, JM (1989) Biochemical changes associated with blood pressure reduction induced by calcium supplementation during pregnancy. American Journal of Obstetrics and Gynecology 160, 684–690.CrossRefGoogle ScholarPubMed
Resnick, LM (1999 a) The cellular ionic basis of hypertension and allied clinical conditions. Progress in Cardiovascular Diseases 42, 1–22.CrossRefGoogle ScholarPubMed
Resnick, LM (1999 b) Therapeutic implications of calcium intake in hypertension. American Journal of Hypertension 14, 82–83.Google Scholar
Resnick, LM (1999 c) The role of dietary calcium in hypertension. American Journal of Hypertension 14, 99–112.CrossRefGoogle Scholar
Resnick, LM, Gupta, RK & Laragh, JH (1984) Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. Proceedings of the National Academy of Sciences USA 81, 6511–6515.CrossRefGoogle ScholarPubMed
Resnick, LM & Laragh, J (1985) Calcium metabolism and parathyroid function in primary aldosteronism. American Journal of Medicine 78, 385–390.CrossRefGoogle ScholarPubMed
Resnick, LM, Laragh, J, Sealey, J & Alderman, M (1983) Divalent cations in essential hypertension: relations between serum ionized calcium, magnesium and plasma renin activity. New England Journal of Medicine 309, 888–891.CrossRefGoogle ScholarPubMed
Resnick, LM, Lewanczuk, RZ, Laragh, JH & Pang, PKT (1993) Parathyroid hypertensive factor-like activity in human essential hypertension. Relationship to plasma renin activity and dietary salt sensitivity. Journal of Hypertension 11, 1235–1241.CrossRefGoogle ScholarPubMed
Resnick, LM, Militianu, DM & Cunnings, AJ (1997) Direct magnetic resonance determination of aortic distensibility in essential hypertension: relation to age, abdominal visceral fat, and in situ intracellular free magnesium. Hypertension 30, 654–659.CrossRefGoogle ScholarPubMed
Reusser, ME & McCarron, DA (1994) Micronutrient effects on blood pressure regulation. Nutrition Reviews 52, 367–375.CrossRefGoogle ScholarPubMed
Ribaya Mercado, JD, Russel, RM, Sayhoun, N, Morrow, FD & Gershoff, SN (1991) Vitamin B6 requirements of elderly men and women. Journal of Nutrition 121, 1062–1074.CrossRefGoogle ScholarPubMed
Rockstroh, JK, Schobel, HP & Vogt-Ladner, G (1997) Blood pressure independent effects of nitrendipine on cardiac structure in patients after renal transplantation. Nephrology, Dialysis and Transplantation 14, 1441–1447.CrossRefGoogle Scholar
Ross, R (1986) The pathogenesis of atherosclerosis: an update. New England Journal of Medicine 314, 488–500.CrossRefGoogle ScholarPubMed
Rostand, SG (1997) Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 30, 150–156.CrossRefGoogle ScholarPubMed
Rowe, JW, Young, JB & Minaker, KL (1981) Effect of insulin and glucose infusion on sympathetic nervous system activity in normal man. Diabetes 30, 219–225.CrossRefGoogle ScholarPubMed
Sacks, FM, Willet, WC, Smith, AM, Brown, LE, Rosner, B & Moore, TJ (1998) Effect on blood pressure of potassium, calcium and magnesium in women with low habitual intake. Hypertension 31, 131–138.CrossRefGoogle ScholarPubMed
Sacks, FM, Obarzanek, E & Windhauser, MM (1995) Rationale and design of the dietary approaches to stop hypertension trial (DASH): a multicentered controlled-feeding study of dietary patterns to lower blood pressure. Annals of Epidemiology 5, 108–118.CrossRefGoogle Scholar
Sagar, S, Kallo, U, Kaul, N, Ganguly, NK & Sharma, BK (1992) Oxygen free radicals in essential hypertension. Molecular and Cellular Biochemistry 111, 103–108.CrossRefGoogle ScholarPubMed
Saito, K, Sano, H, Furuta, Y & Fukuzaki, H (1989) Effect of oral calcium on blood pressure response in salt loaded borderline hypertensive patients. Hypertension 13, 219–226.CrossRefGoogle ScholarPubMed
Sallinen, K, Arvola, P, Wuorela, H, Ruskoaho, H, Vapaatalo, H & Porsti, I (1996) High calcium diet reduces blood pressure in exercised and nonexercised hypertensive rats. American Journal of Hypertension 9, 144–156.CrossRefGoogle ScholarPubMed
Salonen, R, Korpela, H, Nyyssonen, K, Porkkala, E & Salonen, JT (1994) Reduction of blood pressure by antioxidant supplementation: a randomized double-blind clinical trial. Life Chemistry Reports 14, 65–68.Google Scholar
Schleiffer, R, Pernot, F & Gairard, A (1986) Parathyroidectomy, cardiovascular reactivity and calcium distribution in aorta and heart of spontaneously hypertensive rats. Clinical Science 71, 505–511.CrossRefGoogle ScholarPubMed
Schmid, A, Renaud, J & Luxdunski, M (1985) Short term and long term effects of β adrenergic effectors and cyclic AMP on nitrendipine-sensitive voltage-dependent Ca2+ channels of skeletal muscle. Journal of Biological Chemistry 260, 13041–13046.CrossRefGoogle ScholarPubMed
Schoeffler, P & Hoyer, D (1988) Centrally acting hypotensive agents with affinity for 5HT1A binding sites inhibit forskolin-stimulated adenyl cyclase activity in calf hippocampus. British Journal of Pharmacology 95, 975–985.CrossRefGoogle Scholar
Schroeder, HA (1960) Relations between mortality from cardiovascular disease and treated water supplies. Variations in sites and 163 largest municipalities of the United States. Journal of the American Medical Association 172, 1902–1908.CrossRefGoogle Scholar
Shan, J, Bing, L, Taniguchi, N & Pang, PKT (1996) Inhibition of membrane L-type calcium channel activity and intracellular calcium concentration by 24 R, 25-dihydroxyvitamin D3 in vascular smooth muscle. Steroids 61, 657–663.CrossRefGoogle Scholar
Shan, J, Resnick, LM, Lewanczuk, RZ, Karpinski, E, Li, B & Pang, PKT (1993) 1,25-Dihydroxyvitamin D as a cardiovascular hormone. American Journal of Hypertension 6, 983–988.CrossRefGoogle ScholarPubMed
Shan, J, Resnick, LM, Liu, Q, Wu, X, Barbagallo, M & Pang, PKT (1994) Vascular effects of 17β-estradiol in male Sprague-Dawley rats. American Journal of Physiology 266, H967–H973Google ScholarPubMed
SHEP Cooperative Research Group Clinical Trials Branch (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in Elderly Program (SHEP). Journal of the American Medical Association 265, 3255–3264.CrossRefGoogle Scholar
Sherman, DL, Keanney, JF, Biegelsen, ES, Duffy, SJ, Coffman, JD & Vita, JA (2000) Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 35, 936–941.CrossRefGoogle ScholarPubMed
Shetterly, SM, Rewars, M, Hamman, R & Marshall, JA (1994) Patterns and predictors of hypertension incidence among hispanics and nonhispanic whites: the San Luis Valley Diabetes Study. Journal of Hypertension 14, 1095–1102.Google Scholar
Slater, TF (1984) Free radical mechanisms in tissue injury. Biochemical Journal 222, 1–15.CrossRefGoogle ScholarPubMed
Solzbach, U, Hornig, B, Jeserich, M & Just, H (1997) Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 96, 1513–1519.CrossRefGoogle ScholarPubMed
Somjen, D, Somjen, GJ, Harell, A, Mechanic, GL & Binderman, I (1982 a) Partial characterization of a specific high affinity binding macromolecule for 24 R, 25-dihydroxyvitamin D3 in differentiating skeletal mesenchyme. Biochemical and Biophysical Research Communications 106, 664–651.CrossRefGoogle Scholar
Somjen, D, Somjen, GJ, Weisman, Y & Binderman, I (1982 b) Evidence for 24,25-dihydroxycholecalciferol receptors in long bones of new born rats. Biochemical Journal 204, 31–36.CrossRefGoogle Scholar
Spangler, JG, Bell, R & Summerson, JH (1998) Hyperinsulinemia in hypertension. Association with race, abdominal obesity and hyperlipidemia. Archives of Family Medicine 7, 53–56.CrossRefGoogle ScholarPubMed
Stadler, M, Pometta, D & Suenram, A (1981) Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men. Diabetologia 21, 544–548.Google Scholar
Standley, PR, Zhang, F, Ram, JL, Zemel, MB & Sowers, JR (1991) Insulin attenuates vasopressin-induced calcium transient and voltage-dependent calcium current in rat vascular smooth muscle cells. Journal of Clinical Investigation 88, 1230–1236.CrossRefGoogle ScholarPubMed
Suter, PM (1998) Potassium and hypertension. Nutrition Reviews 56, 151–153.CrossRefGoogle ScholarPubMed
Taddei, S, Virdis, A, Ghiadoni, L, Magagna, A & Salvetti, A (1998) Vitamin C improves endothelium-dependent vaso- dilation by restoring nitric oxide activity in essential hypertension. Circulation 97, 2222–2229.CrossRefGoogle Scholar
Tagami, M, Ikeda, K, Nara, Y, Kubota, A, Numano, F & Yamori, Y (1997 a) Insulin-like growth factor-1 attenuates apotosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rats. Laboratory Investigation 74, 613–617.Google Scholar
Tagami, M, Ikeda, K, Yamagata, K, Nara, Y, Fujino, H, Kubota, A, Numano, F & Yamori, Y (1999) Vitamin E prevents apoptosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rats. Laboratory Investigation 79, 609–615.Google ScholarPubMed
Tagami, M, Yamagata, K, Mara, Y, Kubota, A, Numano, F & Yamori, Y (1997 b) Insulin-like growth factors prevent apoptosis in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Laboratory Investigation 74, 603–612.Google Scholar
Taylor, AE (1996) Cardiovascular effects of environmental chemicals. Otolaryngology and Head and Neck Surgery 114, 209–211.CrossRefGoogle ScholarPubMed
The Eclampsia Trial Collabrative Group (1995) Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 345, 1455–1463.CrossRefGoogle Scholar
The Fifth Report of the Joint National Committee on detection, evaluation and treatment of high blood pressure (1993) Archives of Internal Medicine 153, 154–183.CrossRefGoogle Scholar
The Intersalt Cooperative Research Group (1988) Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24-hour urinary sodium and potassium. British Medical Journal 297, 319–328.CrossRefGoogle Scholar
The Sixth Report of the Joint National Committee on detection, evaluation an d treatment of high blood pressure (1997) Archives of Internal Medicine 157, 2413–2446.CrossRefGoogle Scholar
Thierry-Palmer, M, Carlyl, KS, Williams, MD, Tewolde, T, Caines-Mckenzie, S, Bayrog, MA, Emmett, NL, Harris-Hooker, SA, Sanford, GL & Williams, EF (1998) Plasma 25-hydroxyvitamin D concentrations are inversely associated with blood pressure of Dahl salt-sensitive rats. Journal of Steroid Biochemistry and Molecular Biology 66, 255–261.CrossRefGoogle ScholarPubMed
Third Report on Nutrition Monitoring in the United States (1995) Volume 1. Washington DC: US Government Printing Office.Google Scholar
Ting, HH, Timimi, FK, Boles, KS, Creager, SJ, Ganz, P & Creageter, MA (1996) Vitamin C improves endothelium- dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 97, 22–28.CrossRefGoogle ScholarPubMed
Tobian, L (1986) High potassium diets markedly protect against stroke deaths and kidney disease in hypertensive rats, a possible legacy from prehistoric times. Canadian Journal of Physiology and Pharmacology 64, 840–848.CrossRefGoogle ScholarPubMed
Tobian, L, Lange, JM, Ulm, KM, Wold, IJ & Iwai, J (1984) Potassium prevents death from strokes in hypertensive rats without lowering blood pressure. Journal of Hypertension 2, Suppl., 363–366.Google ScholarPubMed
Touyz, RM, Tolloczko, B & Schiffrin, EL (1994) Insulin attenuates agonist-evoked calcium transients in vascular smooth muscle cells. Hypertension 23, Suppl., 125–128.CrossRefGoogle ScholarPubMed
Trezise, DJ, Bell, NJ, Khakh, BS, Michael, AD & Humphrey, PA (1994) P2 purinoceptor antagonist properties of pyridoxal 5-phosphate. European Journal of Pharmacology 259, 295–300.CrossRefGoogle ScholarPubMed
Trials of Hypertension Prevention Collaborative Research Group (1992) The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, phase 1. Journal of the American Medical Association 267, 1213–1220.CrossRefGoogle Scholar
Tully, DB, Allgood, VE & Cidlowski, JA (1994) Modulation of steroid receptor-mediated gene expression by vitamin B6. FASEB Journal 8, 343–349.CrossRefGoogle ScholarPubMed
Vallance, P, Collier, J & Moncada, S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2, 997–1000.CrossRefGoogle ScholarPubMed
Van den Berg, H (1999) Vitamin B6 status and requirements in older adults. British Journal of Nutrition 81, 175–176.CrossRefGoogle ScholarPubMed
Van der Wielen, RPJ, Lowik, MRH, Haller, J, Van den Berg, H, Ferry, M & Van Staveren, WA (1996) Vitamin B6 malnutrition among elderly Europeans: the SENECA study. Journal of Gerontology 51, B417–B424.Google ScholarPubMed
Vane, JR, Aggard, EE & Botting, RM (1990) Regulatory functions of the vascular endothelium. New England Journal of Medicine 323, 27–36.Google ScholarPubMed
Vanhoutte, PM (1999) How to assess endothelial function in human blood vessels. Journal of Hypertension 17, 1047–1058.CrossRefGoogle ScholarPubMed
Vaziri, ND, Liang, K & Ding, Y (1999) Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney International 56, 1492–1498.CrossRefGoogle ScholarPubMed
Vermaak, WH, Barnard, H, Potgieter, GM & Theron, H (1987) Vitamin B6 and coronary artery disease. Epidemiological observations and case studies. Atherosclerosis 63, 235–238.CrossRefGoogle ScholarPubMed
Viswanathan, M, Bose, R & Dakshinamurti, K (1991) Increased calcium influx in caudal artery of rats made hypertensive with pyridoxine deficiency. American Journal of Hypertension 4, 252–255.CrossRefGoogle ScholarPubMed
Viswanathan, M, Paulose, KJ, Lal, KJ & Dakshinamurti, K (1990) Alterations in brain stem α adrenoreceptor activity in pyridoxine-deficient rat model of hypertension. Neuroscience Letters 111, 201–205.CrossRefGoogle ScholarPubMed
Vulchanova, L, Arvidsson, U, Riedi, M, Wang, J, Bull, G, Suprenant, A & North, RA (1996) Differential distribution of two ATP-gated ion channels (P2X receptors) determined by immunocytochemistry. Proceedings of the National Academy of Sciences USA 93, 8063–8067.CrossRefGoogle ScholarPubMed
Wang, TM, Hsu, JF, Lee, WSS & Mathews, JL (1993) Evidence for reduced cancellous bone mass in the spontaneously hypertensive rat. Bone and Mineral 20, 251–264.CrossRefGoogle ScholarPubMed
Wang, X, Dakshinamurti, K, Musat, S & Dhalla, NS (1999) Pyridoxal 5-phosphate is an ATP-receptor antagonist in freshly isolated rat cardiomyocytes. Journal of Molecular and Cellular Cardiology 31, 1063–1072.CrossRefGoogle ScholarPubMed
Weglicki, WB, Mak, IT, Kramer, JH, Dickens, BF, Cassidy, MM, Stafford, RE & Phillips, TM (1996) Role of free radicals and substance P in magnesium deficiency. Cardiovascular Research 31, 677–682.CrossRefGoogle ScholarPubMed
Weinberger, MH (1996) Salt sensitivity of blood pressure in humans. Hypertension 27, 481–490.CrossRefGoogle ScholarPubMed
Wen, Y, Killalea, S, McGettigan, P & Feely, J (1996) Lipid peroxidation and antioxidant vitamin C and E in hypertensive patients. Irish Journal of Medical Sciences 165, 210–212.CrossRefGoogle Scholar
Widgren, BR, Herlitz, H & Wikstrand, J (1992) Increased waist/hip ratio, metabolic disturbances, and family history of hypertension. Hypertension 20, 563–568.CrossRefGoogle ScholarPubMed
Widman, L, Wester, PO, Stegmayr, BG & Wirell, MP (1993) The dose dependent reduction in blood pressure through administration of magnesium: a double blind placebo controlled cross-over trial. American Journal of Hypertension 6, 41–45.CrossRefGoogle Scholar
Witteman, JCM, Willett, WC & Stampfer, MJ (1989) A prospective study of nutritional factors and hypertension among US women. Circulation 80, 1320–1327.CrossRefGoogle ScholarPubMed
Woods, KL & Fletcher, S (1994) Long-term outcome after intravenous magnesium sulfate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial. Lancet 343, 816–819.CrossRefGoogle ScholarPubMed
Xue, H, McCarron, DA & Bukoski, RD (1991) 1,25 (OH)2 vitamin D3 attenuates the loss of resistance artery contractile function associated with incubation in cultured media. Biochemical and Biophysical Research Communications 174, 11–17.CrossRefGoogle Scholar
Yang, CY (1998) Calcium and magnesium in drinking water and risk of death from cerebrovascular disease. Stroke 29, 411–414.CrossRefGoogle ScholarPubMed
Yoshioka, M, Aoyama, K & Matsushita, T (1985) Effects of ascorbic acid on blood pressure and ascorbic acid metabolism in spontaneously hypertensive rats. International Journal of Vitamin and Nutrition Research 55, 301–307.Google ScholarPubMed
Yoshioka, S, Nishino, H, Shiraki, T, Ikeda, K, Koike, H & Okuno, A (1993) Antihypertensive effects of Cs-045 treatment in obese Zucker rats. Metabolism 42, 75–80.CrossRefGoogle ScholarPubMed
Young, DB, Lin, H & McCabe, RD (1995) Potassium's cardiovascular protective mechanisms. American Journal of Physiology 268, R825–R837.Google ScholarPubMed
Zein, M, Areas, JL & Preus, HG (1990) Long-term effects of excess sucrose ingestion on three strains of rats. American Journal of Hypertension 3, 560–562.CrossRefGoogle ScholarPubMed
Zemel, MB (1995) Insulin resistance, obesity and hypertension: an overview. Journal of Nutrition 125, 1715S–1717S.Google ScholarPubMed
Zemel, MB (1998) Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension. Molecular and Cellular Biochemistry 188, 129–136.CrossRefGoogle ScholarPubMed
Zemel, M, Gualdoni, S & Walsh, M (1986) Effects of sodium and calcium on calcium metabolism and blood pressure regulation in hypertensive black adults. Journal of Hypertension 4, Suppl. 5, S364–S365.Google Scholar
Zemel, MB, Johnson, BA & Ambrozy, SA (1992 a) Insulin-stimulated vascular relaxation: Role of Ca2+-ATPase. American Journal of Hypertension 5, 637–641.CrossRefGoogle Scholar
Zemel, MB, Peuler, JD, Sowers, JR & Simpson, L (1992 b) Hypertension in insulin-resistant Zucker obese rats is independent of sympathetic neural support. American Journal of Physiology 262, E368–E371Google ScholarPubMed
Ziemalanski, S, Wartanowicz, M, Potribnicka, K, Burgos de Moor, A, Iwanow, K & Ignatowska-Switalska, M (1991) Effect of exogenous ascorbic acid on experimental hypertension and mineral balance in rats fed low-and high-fat diets. Nutrition 7, 131–135.Google Scholar